| Process: |
GO:6355; regulation of transcription, DNA-templated
GO:30522; intracellular receptor signaling pathway
GO:48511; rhythmic process
GO:7154; cell communication
GO:51716; cellular response to stimulus
GO:6357; regulation of transcription by RNA polymerase II
GO:2674; negative regulation of acute inflammatory response
GO:7507; heart development
GO:8285; negative regulation of cell population proliferation
GO:9409; response to cold
GO:9410; response to xenobiotic stimulus
GO:9612; response to mechanical stimulus
GO:10033; response to organic substance
GO:10629; negative regulation of gene expression
GO:10888; negative regulation of lipid storage
GO:14070; response to organic cyclic compound
GO:19216; regulation of lipid metabolic process
GO:19395; fatty acid oxidation
GO:30308; negative regulation of cell growth
GO:31000; response to caffeine
GO:31100; animal organ regeneration
GO:32966; negative regulation of collagen biosynthetic process
GO:33189; response to vitamin A
GO:33993; response to lipid
GO:35902; response to immobilization stress
GO:42594; response to starvation
GO:43065; positive regulation of apoptotic process
GO:43627; response to estrogen
GO:45598; regulation of fat cell differentiation
GO:45600; positive regulation of fat cell differentiation
GO:45944; positive regulation of transcription by RNA polymerase II
GO:46321; positive regulation of fatty acid oxidation
GO:48662; negative regulation of smooth muscle cell proliferation
GO:48714; positive regulation of oligodendrocyte differentiation
GO:51974; negative regulation of telomerase activity
GO:60100; positive regulation of phagocytosis, engulfment
GO:70165; positive regulation of adiponectin secretion
GO:71300; cellular response to retinoic acid
GO:71306; cellular response to vitamin E
GO:71379; cellular response to prostaglandin stimulus
GO:71380; cellular response to prostaglandin E stimulus
GO:71455; cellular response to hyperoxia
GO:71456; cellular response to hypoxia
GO:1901558; response to metformin
GO:1903243; negative regulation of cardiac muscle hypertrophy in response to stress
GO:1904597; negative regulation of connective tissue replacement involved in inflammatory response wound healing
GO:2000230; negative regulation of pancreatic stellate cell proliferation
GO:10628; positive regulation of gene expression
GO:60965; negative regulation of gene silencing by miRNA
GO:122; negative regulation of transcription by RNA polymerase II
GO:7186; G protein-coupled receptor signaling pathway
GO:30154; cell differentiation
GO:6631; fatty acid metabolic process
GO:45087; innate immune response
GO:45893; positive regulation of transcription, DNA-templated
GO:30509; BMP signaling pathway
GO:42789; mRNA transcription by RNA polymerase II
GO:45892; negative regulation of transcription, DNA-templated
GO:32869; cellular response to insulin stimulus
GO:51091; positive regulation of DNA-binding transcription factor activity
GO:9755; hormone-mediated signaling pathway
GO:6629; lipid metabolic process
GO:48469; cell maturation
GO:1902894; negative regulation of pri-miRNA transcription by RNA polymerase II
GO:1905461; positive regulation of vascular associated smooth muscle cell apoptotic process
GO:42752; regulation of circadian rhythm
GO:1904893; negative regulation of receptor signaling pathway via STAT
GO:1902895; positive regulation of pri-miRNA transcription by RNA polymerase II
GO:16525; negative regulation of angiogenesis
GO:50872; white fat cell differentiation
GO:30512; negative regulation of transforming growth factor beta receptor signaling pathway
GO:60394; negative regulation of pathway-restricted SMAD protein phosphorylation
GO:7584; response to nutrient
GO:45668; negative regulation of osteoblast differentiation
GO:7165; signal transduction
GO:6919; activation of cysteine-type endopeptidase activity involved in apoptotic process
GO:8217; regulation of blood pressure
GO:60392; negative regulation of SMAD protein signal transduction
GO:42593; glucose homeostasis
GO:10862; positive regulation of pathway-restricted SMAD protein phosphorylation
GO:10745; negative regulation of macrophage derived foam cell differentiation
GO:10887; negative regulation of cholesterol storage
GO:71404; cellular response to low-density lipoprotein particle stimulus
GO:2000272; negative regulation of signaling receptor activity
GO:43537; negative regulation of blood vessel endothelial cell migration
GO:43407; negative regulation of MAP kinase activity
GO:10875; positive regulation of cholesterol efflux
GO:1904706; negative regulation of vascular associated smooth muscle cell proliferation
GO:42953; lipoprotein transport
GO:55088; lipid homeostasis
GO:1905599; positive regulation of low-density lipoprotein receptor activity
GO:48384; retinoic acid receptor signaling pathway
GO:60391; positive regulation of SMAD protein signal transduction
GO:1905563; negative regulation of vascular endothelial cell proliferation
GO:30855; epithelial cell differentiation
GO:45165; cell fate commitment
GO:50728; negative regulation of inflammatory response
GO:15909; long-chain fatty acid transport
GO:30514; negative regulation of BMP signaling pathway
GO:1890; placenta development
GO:10742; macrophage derived foam cell differentiation
GO:10891; negative regulation of sequestering of triglyceride
GO:30224; monocyte differentiation
GO:35357; peroxisome proliferator activated receptor signaling pathway
GO:43388; positive regulation of DNA binding
GO:45923; positive regulation of fatty acid metabolic process
GO:60336; negative regulation of interferon-gamma-mediated signaling pathway
GO:60694; regulation of cholesterol transporter activity
GO:90258; negative regulation of mitochondrial fission
GO:1903845; negative regulation of cellular response to transforming growth factor beta stimulus
GO:1900076; regulation of cellular response to insulin stimulus
GO:1904179; positive regulation of adipose tissue development
|
